Replies to post #115389 on Regen BioPharma Inc (RGBP)

[SidVicious]

Only .1751 cents more to go before that happens.

And remember, don't be surprised to wake up tomorrow seeing this at .18 cents because Koos said so in the 10K!

[bme]

What page in the 10k mentioned .18?

[SidVicious]

Is this what you are seeing? If so, that is the so called value of ZANDER and not Regen. If I am incorrect, can you point to where shares of Regen are valued at .18? Btw, found this info on page 53.

NOTE 9. INVESTMENT SECURITIES, RELATED PARY

On June 11, 2018 Regen Biopharma, Inc. was paid a property dividend consisting of 470,588 of the common shares of Zander Therapeutics, Inc.

On November 29, 2018 the Company accepted 725,000 shares of the Series M Preferred stock of Zander Therapeutics, Inc. in satisfaction of prepaid rent and accrued interest owed to the Company collectively amounting to $13,124.

On September 30,2022 the Company revalued 470,588 of the common shares of Zander Therapeutics, Inc. and 725,000 shares of the Series M Preferred stock of Zander Therapeutics, Inc. based on the following inputs:


Fair Value of Intellectual Property $ 1,500
Prepaid Expenses 65,661
Due from Employee 1,071
Note Receivable 64,400
Accrued Interest Receivable 23,989
Investment Securities 8,423,366
Convertible Note Receivable 10,000
Accounts Payable 1,269,041
Notes Payable 400,000
Accrued Expenses Related Parties 162,011
Notes Payable Related Party 5396
Accrued Expenses 203,037
Enterprise Value 10,563,930
Less: Total Debt (2,038,343 )
Portion of Enterprise Value Attributable to Shareholders 8,525,587
Fair Value Per Share $ 0.186168 <this is VALUATION of ZANDER shares and NOT Regen shares>
The abovementioned constitute the Company’s sole related party investment securities as of September 30, 2022